Colossal

Colossal

Private
Austin, TexasHealthcare & Life Scienceshttps://www.colossal.com

Last Round

Series C

Extension

9/17/2025

Est. Valuation

$10.3B

Total Funding Raised

$545M

Momentum Score

25 /100

Company Overview

Colossal Laboratories & Biosciences is a bioscience and genetic engineering company dedicated to developing innovative technologies aimed at advancing genomics, including species de-extinction and ecosystem restoration through the application of CRISPR technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

de-extinctiongenetic engineeringspecies resurrectionmammoth de-extinctionCRISPRecosystem restorationbiotechnologybiotechrewildingsynthetic biologysynbiokeystone speciesconservation technologyanimal cloningadvanced reproductive technologiescomputational biologygenomics softwarebiodiversity credits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Colossal Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Colossal Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C Extension9/17/2025
Series C1/15/2025
Series B1/31/2023
Grant10/5/2022
Series A3/9/2022
Seed
9/13/2021

Secondary Market Activity

Bids, offers, and trades by month

OperationDatePriceSizeShare ClassStructure
OFFER
OFFER

Key People

Founding team and executive leadership

Brian Beard

Co-Founder, Chief Global Strategy And Legal Officer And Board Member

Founding Team

Kent Wakeford

Co-Founder COO Advisor

Founding Team

Ben Lamm

Founder And CEO

Founding Team

Reema Khan

Advisor To Chief Executive Officer

Executive Team

Colossal Investors

Notable investors and investment history

InvestorRounds
TWG GlobalSeries C
S32Series A
Breyer CapitalSeries C, Series B, Series A, Seed
Global Space VenturesSeed
Untamed PlanetSeries A
US Innovative Technology FundSeries B
Builders VCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Won a gold Edison Award for mammalian cloning method.

  • Apr 13, 2026

    Winner at the 2026 Edison Awards.

Colossal Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Colossal Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Colossal's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range236
Year Founded2021
Last Funding9/17/2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.